Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-25-008509

Chief Scientific Officer sold 68,412 shares at $7.35 ($502,828)

  • Chief Scientific Officer acquired 68,412 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROBINS HARLAN S · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-05-01 Exercise or conversion : show line 1 in the form 10b5-1 +68,412 $6.32 $432,364 1,347,936 D
2025-05-01 Sale : show line 2 in the form 10b5-1 −68,412 $7.35 $502,828 1,279,524 D
Open-market sales · 68,412 sh · avg $7.35 · $502,828

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-05-01 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −68,412 0 D
Loading xslF345X05/form4.xml…